ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,039 filers reported holding ASTRAZENECA PLC in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $573 | -7.4% | 8,457 | -2.2% | 0.03% | -6.7% |
Q2 2023 | $619 | -22.7% | 8,645 | -25.1% | 0.03% | -25.0% |
Q1 2023 | $801 | -12.1% | 11,539 | -14.1% | 0.04% | -20.0% |
Q4 2022 | $911 | -99.9% | 13,438 | -11.3% | 0.05% | +6.4% |
Q3 2022 | $831,000 | -20.3% | 15,149 | -4.1% | 0.05% | -17.5% |
Q2 2022 | $1,043,000 | +4.6% | 15,791 | +5.1% | 0.06% | +23.9% |
Q1 2022 | $997,000 | +20.6% | 15,028 | +5.9% | 0.05% | +27.8% |
Q4 2021 | $827,000 | -12.0% | 14,191 | -9.3% | 0.04% | -20.0% |
Q3 2021 | $940,000 | +26.9% | 15,651 | +26.5% | 0.04% | +28.6% |
Q2 2021 | $741,000 | +8.0% | 12,370 | -10.4% | 0.04% | -7.9% |
Q1 2021 | $686,000 | +7.9% | 13,799 | +8.5% | 0.04% | -32.1% |
Q4 2020 | $636,000 | -8.2% | 12,722 | +0.6% | 0.06% | -15.2% |
Q3 2020 | $693,000 | +15.9% | 12,640 | +11.7% | 0.07% | +15.8% |
Q2 2020 | $598,000 | +26.7% | 11,313 | +7.0% | 0.06% | +1.8% |
Q1 2020 | $472,000 | +3.7% | 10,574 | +15.8% | 0.06% | +40.0% |
Q4 2019 | $455,000 | +7.1% | 9,130 | -4.4% | 0.04% | -4.8% |
Q3 2019 | $425,000 | +2.9% | 9,546 | -4.5% | 0.04% | 0.0% |
Q2 2019 | $413,000 | -1.0% | 9,995 | -3.0% | 0.04% | -6.7% |
Q1 2019 | $417,000 | +7.8% | 10,309 | +1.1% | 0.04% | -8.2% |
Q4 2018 | $387,000 | +23.6% | 10,200 | +29.1% | 0.05% | +36.1% |
Q3 2018 | $313,000 | +7.9% | 7,900 | -4.4% | 0.04% | 0.0% |
Q2 2018 | $290,000 | -0.7% | 8,266 | -1.1% | 0.04% | -5.3% |
Q1 2018 | $292,000 | -2.3% | 8,358 | -3.1% | 0.04% | +2.7% |
Q4 2017 | $299,000 | -23.3% | 8,625 | -25.0% | 0.04% | -27.5% |
Q3 2017 | $390,000 | -2.7% | 11,504 | -2.2% | 0.05% | -1.9% |
Q2 2017 | $401,000 | -2.4% | 11,767 | -10.8% | 0.05% | -7.1% |
Q1 2017 | $411,000 | +20.5% | 13,197 | +5.8% | 0.06% | +12.0% |
Q4 2016 | $341,000 | +58.6% | 12,469 | +90.3% | 0.05% | +56.2% |
Q3 2016 | $215,000 | -26.1% | 6,554 | +61.0% | 0.03% | -28.9% |
Q3 2014 | $291,000 | -38.0% | 4,070 | -35.5% | 0.04% | -40.0% |
Q2 2014 | $469,000 | +83.9% | 6,314 | +60.9% | 0.08% | +66.7% |
Q1 2014 | $255,000 | -42.6% | 3,925 | -47.5% | 0.04% | -57.1% |
Q4 2013 | $444,000 | +107.5% | 7,481 | +65.3% | 0.10% | +78.0% |
Q2 2013 | $214,000 | – | 4,527 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |